BRITTANY SHORT: Open Payments
NPI 1093476814 · ASHLAND, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,067 in 113 payments from 18 companies in 2025. Trend: 2023 $1,534 · 2024 $1,875 · 2025 $2,067
Food & beverage: $2,067
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 34 | $591 |
| Ardelyx, Inc. | 26 | $413 |
| Regeneron Healthcare Solutions, Inc. | 10 | $212 |
| Janssen Biotech, Inc. | 11 | $204 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $137 |
| Novo Nordisk Inc | 4 | $94 |
| Celltrion USA Inc. | 3 | $69 |
| Madrigal Pharmaceuticals | 4 | $66 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $55 |
| GENZYME CORPORATION | 2 | $40 |
Products named: IBSRELA, RINVOQ, DUPIXENT, TREMFYA, CREON, ENTYVIO, Wegovy, VEGZELMA.
Industry payments across KY — which companies pay providers there.
